Christopher Haqq - Title: Executive Vice President, Head of R&D and Chief Medical Officer at Elicio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Title: Executive Vice President, Head of R&D and Chief Medical Officer
Stock Symbol
ELTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Haqq since 9/11/2023

Holdings reported by Christopher Haqq for Elicio Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 32K $186K $5.81 Jun 1, 2023 Direct
Stock Option (right to buy) 28.2K Feb 1, 2024 Direct Common Stock

Transactions reported by Christopher Haqq for Elicio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.